BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/29/2016 9:02:00 AM | Browse: 1264 | Download: 2288
 |
Received |
|
2016-02-10 15:02 |
 |
Peer-Review Started |
|
2016-02-14 15:19 |
 |
To Make the First Decision |
|
2016-03-21 13:58 |
 |
Return for Revision |
|
2016-03-21 18:40 |
 |
Revised |
|
2016-03-31 10:54 |
 |
Second Decision |
|
2016-04-06 16:56 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2016-04-18 11:55 |
 |
Articles in Press |
|
2016-04-18 11:55 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-06-20 17:27 |
 |
Publish the Manuscript Online |
|
2016-06-29 09:02 |
ISSN |
2220-6124 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Basic Study |
Article Title |
Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats
|
Manuscript Source |
Invited Manuscript |
All Author List |
Michelle HT Ta, Kristina G Schwensen, David Liuwantara, David L Huso, Terry Watnick and Gopala K Rangan |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Health and Medical Research Council of Australia |
457575 |
Baltimore Polycystic Kidney Disease Research and Clinical Core Center |
P30DK090868 |
National Health and Medical Research Council of Australia |
632647 |
Baltimore Polycystic Kidney Disease Research and Clinical Core Center |
DK095036 |
|
Corresponding Author |
Gopala K Rangan, MBBS, PhD, Associate Professor of Medicine, Centre for Transplant and Renal Research, Westmead Institute for Medical Research and the University of Sydney, Level 5, 176 Hawkesbury Road (PO Box 412), Westmead, Sydney 2145, Australia. g.rangan@sydney.edu.au
|
Key Words |
Inflammation; Nuclear factor-κB; Polycystic kidney disease; Tumour necrosis factor alpha; Chemokine CCL2 |
Core Tip |
Until now, there has been limited information regarding the specific nuclear factor (NF)-κB proteins involved in polycystic kidney disease (PKD) and their expression throughout disease progression. Our study demonstrated that a diverse array of NF-κB proteins is expressed in the renal cyst-lining cells of a chronic rodent model of PKD, and that NF-κB expression is constitutive over time. NF-κB was also identified in human PKD, suggesting that NF-κB upregulation is common to renal cystic disease models. Our data suggest that components of both the canonical and non-canonical NF-κB pathway are upregulated in PKD. Future studies should be directed at verifying whether specific NF-κB inhibition can attenuate interstitial inflammation and cyst growth, and slow the decline in renal function in in vivo models of PKD. |
Publish Date |
2016-06-29 09:02 |
Citation |
Ta MHT, Schwensen KG, Liuwantara D, Huso DL, Watnick T, Rangan GK. Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats. World J Nephrol 2016; 5(4): 339-357 |
URL |
http://www.wjgnet.com/2220-6124/full/v5/i4/339.htm |
DOI |
http://dx.doi.org/10.5527/wjn.v5.i4.339 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345